Seguir
Kwang-Hee Shin
Kwang-Hee Shin
Professor, Department of Pharmacy, Kyungpook National University
Email confirmado em knu.ac.kr
Título
Citado por
Citado por
Ano
Evaluation of endogenous metabolic markers of hepatic CYP3A activity using metabolic profiling and midazolam clearance
KH Shin, MH Choi, KS Lim, KS Yu, IJ Jang, JY Cho
Clinical pharmacology & therapeutics 94 (5), 601-609, 2013
1272013
Reduced valproic acid serum concentrations due to drug interactions with carbapenem antibiotics: overview of 6 cases
MK Park, KS Lim, TE Kim, HK Han, SJ Yi, KH Shin, JY Cho, SG Shin, ...
Therapeutic drug monitoring 34 (5), 599-603, 2012
772012
Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose—block-randomized, double-blind, placebo …
KS Lim, JR Kim, YJ Choi, KH Shin, KP Kim, JH Hong, JY Cho, HS Shin, ...
Clinical therapeutics 30 (10), 1817-1830, 2008
522008
Tolerability and pharmacokinetics of lobeglitazone (CKD-501), a peroxisome proliferator-activated receptor-γ agonist: a single-and multiple-dose, double-blind, randomized …
JW Kim, JR Kim, SJ Yi, KH Shin, HS Shin, SH Yoon, JY Cho, DH Kim, ...
Clinical therapeutics 33 (11), 1819-1830, 2011
462011
Effect of green tea catechins on the pharmacokinetics of digoxin in humans
TE Kim, KH Shin, JE Park, MG Kim, YM Yun, DH Choi, KJ Kwon, J Lee
Drug Design, Development and Therapy, 2139-2147, 2018
422018
Urinary 6β-hydroxycortisol/cortisol ratio most highly correlates with midazolam clearance under hepatic CYP3A inhibition and induction in females: a pharmacometabolomics approach
KH Shin, LY Ahn, MH Choi, JY Moon, J Lee, IJ Jang, KS Yu, JY Cho
The AAPS journal 18, 1254-1261, 2016
412016
The effect of the newly developed angiotensin receptor II antagonist fimasartan on the pharmacokinetics of atorvastatin in relation to OATP1B1 in healthy male volunteers
KH Shin, TE Kim, SE Kim, MG Lee, IS Song, SH Yoon, JY Cho, IJ Jang, ...
Journal of Cardiovascular Pharmacology 58 (5), 492-499, 2011
402011
Metabolite changes in risk of type 2 diabetes mellitus in cohort studies: A systematic review and meta-analysis
JE Park, HR Lim, JW Kim, KH Shin
Diabetes research and clinical practice 140, 216-227, 2018
362018
Exploration of biomarkers for amoxicillin/clavulanate‐induced liver injury: multi‐omics approaches
J Lee, SC Ji, B Kim, S Yi, KH Shin, JY Cho, KS Lim, SH Lee, SH Yoon, ...
Clinical and translational science 10 (3), 163-171, 2017
362017
Aspirin decreases systemic exposure to clopidogrel through modulation of P‐glycoprotein but does not alter its antithrombotic activity
J Oh, D Shin, KS Lim, S Lee, KH Jung, K Chu, KS Hong, KH Shin, JY Cho, ...
Clinical Pharmacology & Therapeutics 95 (6), 608-616, 2014
322014
Trough concentration over 12.1 mg/L is a major risk factor of vancomycin-related nephrotoxicity in patients with therapeutic drug monitoring
HK Han, H An, KH Shin, D Shin, SH Lee, JH Kim, SH Cho, HR Kang, ...
Therapeutic drug monitoring 36 (5), 606-611, 2014
302014
Assessment of the drug–drug interactions between fimasartan and hydrochlorothiazide in healthy volunteers
H Jeon, KS Lim, KH Shin, JW Kim, SH Yoon, JY Cho, SG Shin, IJ Jang, ...
Journal of Cardiovascular Pharmacology 59 (1), 84-91, 2012
292012
A pharmacometabolomic approach to predict response to metformin in early-phase type 2 diabetes mellitus patients
JE Park, GH Jeong, IK Lee, YR Yoon, KH Liu, N Gu, KH Shin
Molecules 23 (7), 1579, 2018
262018
Quantitative analysis of four catechins from green tea extract in human plasma using ultra-performance liquid chromatography-tandem mass spectrometry for pharmacokinetic studies
JE Park, TE Kim, KH Shin
Molecules 23 (4), 984, 2018
202018
Comparison of pharmacokinetics between new quinolone antibiotics: the zabofloxacin hydrochloride capsule and the zabofloxacin aspartate tablet
HK Han, SE Kim, KH Shin, C Lim, KS Lim, KS Yu, JY Cho
Current medical research and opinion 29 (10), 1349-1355, 2013
202013
The effects of ketoconazole and rifampicin on the pharmacokinetics of mirodenafil in healthy Korean male volunteers: an open-label, one-sequence, three-period, three-treatment …
KH Shin, BH Kim, TE Kim, JW Kim, SJ Yi, SH Yoon, JY Cho, SG Shin, ...
Clinical therapeutics 31 (12), 3009-3020, 2009
202009
Pharmacokinetic comparison of a new glimepiride 1-mg+ metformin 500-mg combination tablet formulation and a glimepiride 2-mg+ metformin 500-mg combination tablet formulation: a …
BH Kim, KH Shin, JW Kim, KS Lim, K Kim, JR Kim, JY Cho, SG Shin, ...
Clinical therapeutics 31 (11), 2755-2764, 2009
202009
Bioanalytical method using ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry (UHPL-CHRMS) for the detection of metformin in human plasma
YJ Kang, HC Jeong, TE Kim, KH Shin
Molecules 25 (20), 4625, 2020
192020
Population pharmacokinetic analysis of tramadol and O-desmethyltramadol with genetic polymorphism of CYP2D6
J Lee, HD Yoo, JW Bae, S Lee, KH Shin
Drug design, development and therapy, 1751-1761, 2019
182019
Metabolite signature associated with stress susceptibility in socially defeated mice
VV Prabhu, TB Nguyen, Y Cui, YE Oh, YH Piao, HM Baek, JY Kim, ...
Brain Research 1708, 171-180, 2019
182019
O sistema não pode efectuar a operação agora. Tente mais tarde.
Artigos 1–20